Skip to main content
Premium Trial:

Request an Annual Quote

Mendel and Monsanto Extend Plant Functional Genomics Partnership Through 2011

NEW YORK, July 10 (GenomeWeb News) - Mendel Biotechnology said today that it has extended through 2011 a research and commercialization partnership with Monsanto that began in 1997.
Monsanto and Mendel plan to add a systems biology component to the program, in order to develop "an integrated framework for predictive control of plant gene expression. "
Under the original agreement, Mendel carried out a functional genomics program in Arabidopsis in order to study factors that control plant gene expression. That program identified several genes that have been shown to enhance the yield of major crops in field trials, Mendel said.
These genes are currently in early commercial development by Monsanto and the companies will continue to advance them toward commercialization under the extended agreement.
Mendel will receive milestone and royalty payments from products that Monsanto commercializes.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.